-
Mashup Score: 1A View In Focus • A podcast on Anchor - 1 year(s) ago
Dino Di Palma, Managing Partner at True North Advisory, sits down with technology startups and high-growth companies to share their stories about entrepreneurship, leadership, strategy, management, and fundraising. He interviews founders, operators, investors, and innovators in the technology space.
Source: AnchorCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3A View In Focus • A podcast on Anchor - 1 year(s) ago
Dino Di Palma, Managing Partner at True North Advisory, sits down with technology startups and high-growth companies to share their stories about entrepreneurship, leadership, strategy, management, and fundraising. He interviews founders, operators, investors, and innovators in the technology space.
Source: AnchorCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
-
Mashup Score: 6A View In Focus • A podcast on Anchor - 1 year(s) ago
Dino Di Palma, Managing Partner at True North Advisory, sits down with technology startups and high-growth companies to share their stories about entrepreneurship, leadership, strategy, management, and fundraising. He interviews founders, operators, investors, and innovators in the technology space.
Source: AnchorCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
-
Mashup Score: 8A View In Focus • A podcast on Anchor - 2 year(s) ago
Dino Di Palma, Managing Partner at True North Advisory, sits down with technology startups and high-growth companies to share their stories about entrepreneurship, leadership, strategy, management, and fundraising. He interviews founders, operators, investors, and innovators in the technology space.
Source: AnchorCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
-
Mashup Score: 3A View In Focus • A podcast on Anchor - 2 year(s) ago
Dino Di Palma, Managing Partner at True North Advisory, sits down with technology startups and high-growth companies to share their stories about entrepreneurship, leadership, strategy, management, and fundraising. He interviews founders, operators, investors, and innovators in the technology space.
Source: AnchorCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @tn_advisory: Listen here: https://t.co/Olixcfzzw3 #truenorthadvisory #podcast #thefoodproject #listennow #business #entreprenur #leade…
-
-
Mashup Score: 4POSNAcademy - 3 year(s) ago
0 likes 0 plays 0 Nick Fletcher, MD speaks with Dr. Dror Paley of the Paley Institute to discuss Dr. Paley’s career, his history of innovation, the development of the Paley… …
Source: www.posnacademy.orgCategories: Latest Headlines, OrthopedicsTweet-
📲NEW EPISODE! Nick Fletcher, MD speaks with Dr. Dror Paley of the Paley Institute to discuss his career, history of innovation, the development of the Paley Institute, and more. Listen now: https://t.co/D9TzzDy9AB #posna #pediatricorthopaedics #newepisode #listennow https://t.co/2TJDJKYOlB
-
-
Mashup Score: 0
The identification of predictive biomarkers for immunotherapy response is an area of intense research interest. In this conversation with Alicia Morgans, MD, MPH, Srikala Sridhar MD, MSc, FRCPC highlights her presentation from the European Society for Medical Oncology (ESMO) 2020 virtual meeting. At this meeting, Dr. Sridhar presented an assessment of potential biomarkers for response within…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Association between clinical outcomes and exploratory biomarkers in the #JAVELIN Bladder 100 trial, advanced #UrothelialCarcinoma. @kalasri3 @UofT joins @CaPsurvivorship @NUFeinbergMed discussing her #ESMO20 presentation on UroToday. #ListenNow > https://t.co/rSAtlA7kdf @UHN https://t.co/AwRQ3pAVHj
-
-
Mashup Score: 0
In this discussion, Stephen Freedland, MD, joins Alicia Morgans, MD, MPH, to discuss a health economics study that was recently published titled, Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer. The objective of this study was to evaluate the association of prostate-specific antigen doubling time…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Predictors of survival, healthcare resource utilization, and healthcare costs in #veterans with #nmCRPC. @SFreedlandMD @CedarsSinai joins @CaPsurvivorship @NUFeinbergMed to discuss his recently published health economics study. #ListenNow on UroToday > https://t.co/gMTYDVIDk6 https://t.co/yBjrV60Bow
-
-
Mashup Score: 0
The identification of predictive biomarkers for immunotherapy response is an area of intense research interest. In this conversation with Alicia Morgans, MD, MPH, Srikala Sridhar MD, MSc, FRCPC highlights her presentation from the European Society for Medical Oncology (ESMO) 2020 virtual meeting. At this meeting, Dr. Sridhar presented an assessment of potential biomarkers for response within…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Association between clinical outcomes and exploratory biomarkers in the #JAVELIN Bladder 100 trial, advanced #UrothelialCarcinoma. @kalasri3 @UofT joins @CaPsurvivorship @NUFeinbergMed discussing her #ESMO20 presentation on UroToday. #ListenNow > https://t.co/rSAtlA7kdf @UHN https://t.co/q8mrPnyAQC
-
-
Mashup Score: 0The Use of Active Surveillance in Metastatic Kidney Disease - Jaime Landman and Monty Pal - 4 year(s) ago
In this episode of Kidney Cancer Today, Jaime Landman helps Monty Pal dissect some of the biggest issues on active surveillance for renal cell carcinoma. The following questions were discussed. Who is the right patient for active surveillance? Can a T1b patient be a candidate for active surveillance? What are the best clinical practices post five years after resection in the surveillance…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
The use of active surveillance in metastatic kidney disease. @jaimelandmanuci @UCI_Urology and @montypal @cityofhope dissect some of the biggest issues on AS for renal cell carcinoma. #ListenNow on UroToday > https://t.co/BrnZnd7sUQ https://t.co/zeixIbPwkj
-
Listen to the first episode of A View In Focus, Season 2 featuring Inorsa's CEO, Sean Shahini, from @tn_advisory here: https://t.co/zcYgYOpnOt #truenorthadvisory #podcast #inorsa #aviewinfocus #listennow #business #entreprenur #leadership https://t.co/JTfkj9gUAB